Home/ Supplements/ Vitamin D/ Ageless Mind

Ageless Mind

product on market Tablet or Pill Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 44% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains Vitamin D3, B-6, and folate, which are supported by strong evidence for maintaining cognitive function and neurological health. These nutrients play essential roles in neurotransmitter synthesis and homocysteine regulation. However, the overall evidence coverage for this specific ingredient combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ageless Mind
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
666 IU (167% DV)
1.1× RDA — within safe limits 608 studies (A:16, B:251)
50 mg (2500% DV)
38.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
266 mcg (667% DV)
Within RDA (0.7× RDA) 226 studies (A:10, B:105)
330 mcg (5440% DV)
137.5× RDA — above typical dose 139 studies (A:1, B:44)
33 mg (333% DV)
6.6× RDA — above typical dose 2 studies — no high-quality reviews
66 mg (17% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
66 mcg (55% DV)
1.9× RDA — within safe limits 199 studies (A:1, B:55)
Sodium
5 mg (1% DV)
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
Malic Acid
200 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
L-Pyroglutamic Acid
100 mg
Cinnamomum spp. bark extract
100 mg
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Market median: 100.0mg (108 products)
DMAE
45 mg
Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Hops cone extract
33 mg
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
16 mg
Market median: 100.0mg (70 products)
Vinpocetine
6 mg
133 mcg
Market median: 0.15mg (41 products)

Other Ingredients

silicified Microcrystalline Cellulose Stearic Acid Acacia Gum modified Cellulose Gum Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 to 2 tablets 3 times daily. Do not exceed recommended dosage. Read entire label before using.

Warnings & Precautions

Contains soy.

Do not exceed recommended dosage. Read entire label before using.

Warning: Do not use this product if you are pregnant, may become pregnant, or breastfeeding. If you have epilepsy, high blood pressure, heart problems, or are taking anticholinergic drugs, cholinergic drugs, acetylcholinesterase inhibitors, or drugs that affect blood coagulation or blood pressure such as prescription vitamin K, heparin, warfarin (Coumadin), diuretics, ACE inhibitors, beta-blockers, aspirin or blood-thinning medications, consult your physician before using this product.

If symptoms of nausea, vomiting, diarrhea, incontinence, or muscle twitches occur, discontinue use or reduce dosage and consult your physician.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

Contains soy.

Additional Information

For memory & cognitive function

Preliminary research shows that the ingredients in Ageless Mind support natural biochemical cycles of beta-amyloid clearance.

SN2379 REV K173-B

Metadata

Product Details

UPC / SKU0 21078 02379 1
DSLD Entry Date2018-09-21
Product TypeOther Combinations
FormTablet or Pill
DSLD ID181686
Data Updated2026-04-11
Research

Research Evidence

872
Research Sources
53
Avg Quality
309
Meta Analysis
309
Clinical Trial
111
Rct
71
Systematic Review
55
Guideline
4
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
2
Observational
1
Openfda Safety
A Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D supplementation for prevention of cancer in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Interventions for preventing falls in older people in care facilities and hospitals
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Drugs for preventing lung cancer in healthy people
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A Interventions for preventing falls in older people living in the community
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Vitamin D →
Compare

Similar Products

View all Vitamin D products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.